GLP-1RAs and tirzepatide may reduce heart failure risk in obese but not in non-obese patients with cardiovascular or renal disease: A systematic review and meta-analysis
Ju Zhang, Xiangfeng Guan, Mo-Wei Kong, Meng Xia, Yu Yang, Chunxiang Zhang
Topics & Concepts
MedicineHeart failureInternal medicineCardiologyIntensive care medicineKidney diseaseObesityDiseaseMEDLINEBlood pressureRisk factorKidneyRisk assessmentDiabetes mellitusDiabetes Treatment and ManagementCardiovascular Function and Risk FactorsHeart Failure Treatment and Management